Rapid Commercial Test for Campylobacter Evaluated
|
By LabMedica International staff writers Posted on 13 Feb 2014 |
|
Image: Scanning electron micrograph of Campylobacter jejuni (Photo courtesy of Jonas Waldenström).
The effectiveness of a new rapid immunochromatographic test for the qualitative detection of Campylobacter antigens in pathologic feces has been evaluated.
The genus Campylobacter belongs to the family Campylobacteriaceae and contains 18 species, including Campylobacter jejuni, the cause of around 90% of acute Campylobacter enteritis cases in humans, a zoonotic disease prevalent worldwide and transmitted via water and food.
Microbiologists at the Hospital Universitario Virgen de las Nieves (Granada, Spain) examined 300 consecutive samples of fresh feces samples from patients diagnosed with diarrhea in primary (57.6%) and specialist (42.4%) care; 50.6% were from adults and 49.4% from children under 14 years of age, between March and May 2013. They were processed for coproculture immediately on their reception by culture and colonies suspected of being enteropathogenic were identified by means of the Biotyper system (Bruker Daltonics; Billerica, MA, USA).
The RIDAQUICK Campylobacter immunochromatographic test (R-biopharm AG; Darmstadt, Germany) was evaluated and compared with culture results. Campylobacter was considered present when the microorganism was isolated or when the specific DNA was detected in samples with contradictory culture and immunochromatographic findings. The results of the RIDAQUICK Campylobacter test was considered positive when violet red lines could be seen in the control (C) and test (T) bands, negative when the control line alone appeared, and invalid when no line could be observed.
Campylobacter was detected in 37 (12.3%) of all samples, and the gold-standard culture method was positive for C. jejuni in 31 (83.78%) of these. A different enteropathogen was detected in 12 (8.11%) of the samples from children. The culture and immunochromatographic results differed in 12 samples (4% of the total), which were therefore studied by polymerase chain reaction (PCR); six of these samples were culture-negative and PCR-positive and one was culture positive (C. jejuni) and PCR-negative.
The diagnostic accuracy values of the RIDAQUICK Campylobacter assay versus culture were: sensitivity of 87%, specificity of 97%, and positive and negative predictive values of 77% and 98%, respectively. RIDAQUICK Campylobacter was found to be a rapid test for the diagnosis of enteritis due to Campylobacter and could be an option for the clinical diagnosis of one of the main causes of bacterial enteritis in resource-limited settings. The study was published in the February 2014 issue of the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Hospital Universitario Virgen de las Nieves
Bruker Daltonics
R-biopharm AG
The genus Campylobacter belongs to the family Campylobacteriaceae and contains 18 species, including Campylobacter jejuni, the cause of around 90% of acute Campylobacter enteritis cases in humans, a zoonotic disease prevalent worldwide and transmitted via water and food.
Microbiologists at the Hospital Universitario Virgen de las Nieves (Granada, Spain) examined 300 consecutive samples of fresh feces samples from patients diagnosed with diarrhea in primary (57.6%) and specialist (42.4%) care; 50.6% were from adults and 49.4% from children under 14 years of age, between March and May 2013. They were processed for coproculture immediately on their reception by culture and colonies suspected of being enteropathogenic were identified by means of the Biotyper system (Bruker Daltonics; Billerica, MA, USA).
The RIDAQUICK Campylobacter immunochromatographic test (R-biopharm AG; Darmstadt, Germany) was evaluated and compared with culture results. Campylobacter was considered present when the microorganism was isolated or when the specific DNA was detected in samples with contradictory culture and immunochromatographic findings. The results of the RIDAQUICK Campylobacter test was considered positive when violet red lines could be seen in the control (C) and test (T) bands, negative when the control line alone appeared, and invalid when no line could be observed.
Campylobacter was detected in 37 (12.3%) of all samples, and the gold-standard culture method was positive for C. jejuni in 31 (83.78%) of these. A different enteropathogen was detected in 12 (8.11%) of the samples from children. The culture and immunochromatographic results differed in 12 samples (4% of the total), which were therefore studied by polymerase chain reaction (PCR); six of these samples were culture-negative and PCR-positive and one was culture positive (C. jejuni) and PCR-negative.
The diagnostic accuracy values of the RIDAQUICK Campylobacter assay versus culture were: sensitivity of 87%, specificity of 97%, and positive and negative predictive values of 77% and 98%, respectively. RIDAQUICK Campylobacter was found to be a rapid test for the diagnosis of enteritis due to Campylobacter and could be an option for the clinical diagnosis of one of the main causes of bacterial enteritis in resource-limited settings. The study was published in the February 2014 issue of the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Hospital Universitario Virgen de las Nieves
Bruker Daltonics
R-biopharm AG
Gold Member
Troponin T QC
Troponin T Quality Control
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
Latest Microbiology News
- Handheld Device Deliver Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower... Read more
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
Molecular Diagnostics
view channel
RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms
Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more
First Of Its Kind Test Uses microRNAs to Predict Toxicity from Cancer Therapy
Many men with early-stage prostate cancer receive stereotactic body radiotherapy (SBRT), a highly precise form of radiation treatment that is completed in just five sessions. Compared to traditional radiation,... Read more
Novel Cell-Based Assay Provides Sensitive and Specific Autoantibody Detection in Demyelination
Anti-myelin-associated glycoprotein (MAG) antibodies serve as markers for an autoimmune demyelinating disorder that affects the peripheral nervous system, leading to sensory impairment. Anti-MAG-IgM antibodies... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Pathology
view channel
Advanced Imaging Reveals Mechanisms Causing Autoimmune Disease
Myasthenia gravis, an autoimmune disease, leads to muscle weakness that can affect a range of muscles, including those needed for basic actions like blinking, smiling, or moving. Researchers have long... Read more
AI Model Effectively Predicts Patient Outcomes in Common Lung Cancer Type
Lung adenocarcinoma, the most common form of non-small cell lung cancer (NSCLC), typically adopts one of six distinct growth patterns, often combining multiple patterns within a single tumor.... Read more
Technology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Industry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
